Treatment of Tumors in Dogs with Triethylene Glycol Diglycidyl Ether
Author Information
Author(s): L. N. Owen
Primary Institution: Department of Veterinary Clinical Studies, School of Veterinary Medicine, Cambridge
Hypothesis
Can triethylene glycol diglycidyl ether effectively treat spontaneous tumors in dogs?
Conclusion
The treatment showed some regression of tumors in dogs, particularly in cases of tonsillar epithelioma and reticulum cell sarcoma, but also had significant toxic effects.
Supporting Evidence
- Nine out of 22 dogs treated intravenously showed regression of tumors.
- Two dogs with tonsillar epithelioma had significant improvement after treatment.
- Three dogs treated intra-arterially showed good regression without early death.
Takeaway
This study tested a special medicine on sick dogs with tumors to see if it could help them feel better, and it worked a little for some dogs but also made them sick.
Methodology
Dogs with inoperable malignant tumors were treated with intravenous or intra-arterial injections of triethylene glycol diglycidyl ether.
Potential Biases
Potential bias due to lack of randomization and selection of cases based on owner cooperation.
Limitations
The study lacked a controlled design and had a small sample size, making it difficult to draw definitive conclusions.
Participant Demographics
Dogs aged between 6 and 15 years, with a majority being older and having inoperable tumors.
Want to read the original?
Access the complete publication on the publisher's website